This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Learn more here.

MGNX Insider Trading

Insider Ownership Percentage: 10.00%
Insider Buying (Last 12 Months): $1,794,650.00
Insider Selling (Last 12 Months): $859,890.84

MacroGenics Insider Trading History Chart

This chart shows the insider buying and selling history at MacroGenics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

MacroGenics Share Price & Price History

Current Price: $19.06
Price Change: Price Increase of +1.12 (6.24%)
As of 03/1/2024 01:00 AM ET

This chart shows the closing price history over time for MGNX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Full details and steps to take here.

MacroGenics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/26/2024Jeffrey Stuart PetersVPSell16,124$17.22$277,655.288,895View SEC Filing Icon  
2/1/2024Ezio BonviniSVPSell13,316$15.00$199,740.0074,668View SEC Filing Icon  
1/19/2024Ezio BonviniSVPSell13,316$12.00$159,792.0087,984View SEC Filing Icon  
12/20/2023Ezio BonviniSVPSell18,880$10.08$190,310.40101,300View SEC Filing Icon  
10/2/2023Target N V BiotechMajor ShareholderBuy150,000$4.46$669,000.009,929,963View SEC Filing Icon  
9/7/2023Target N V BiotechMajor ShareholderBuy200,000$5.26$1,052,000.009,779,963View SEC Filing Icon  
8/30/2023Edward HurwitzDirectorBuy15,000$4.91$73,650.0033,074View SEC Filing Icon  
3/10/2023Jeffrey Stuart PetersVPSell5,372$6.03$32,393.16View SEC Filing Icon  
2/14/2023Target N V BiotechMajor ShareholderBuy500,000$5.07$2,535,000.009,579,963View SEC Filing Icon  
1/19/2023Target N V BiotechMajor ShareholderBuy150,000$5.30$795,000.009,079,963View SEC Filing Icon  
12/27/2022Target N V BiotechMajor ShareholderBuy200,000$5.61$1,122,000.008,929,963View SEC Filing Icon  
12/23/2022Target N V BiotechMajor ShareholderBuy200,000$5.88$1,176,000.008,729,963View SEC Filing Icon  
11/22/2022Target N V BiotechMajor ShareholderBuy300,000$5.96$1,788,000.008,529,963View SEC Filing Icon  
10/24/2022Target N V BiotechMajor ShareholderBuy250,000$4.36$1,090,000.008,229,963View SEC Filing Icon  
10/21/2022Target N V BiotechMajor ShareholderBuy250,000$4.63$1,157,500.007,979,963View SEC Filing Icon  
10/19/2022Target N V BiotechMajor ShareholderBuy168,422$3.70$623,161.407,443,986View SEC Filing Icon  
6/15/2022James KarrelsCFOBuy40,000$2.47$98,800.00191,776View SEC Filing Icon  
11/19/2021Target N V BiotechMajor ShareholderBuy200,000$18.50$3,700,000.00View SEC Filing Icon  
9/28/2021Target N V BiotechMajor ShareholderBuy100,000$20.64$2,064,000.00View SEC Filing Icon  
9/16/2021Target N V BiotechMajor ShareholderBuy400,000$20.94$8,376,000.00View SEC Filing Icon  
7/16/2021Thomas SpitznagelSVPSell5,000$25.01$125,050.005,000View SEC Filing Icon  
6/21/2021Target N. V. BiotechMajor ShareholderBuy75,000$21.74$1,630,500.006,275,564View SEC Filing Icon  
6/15/2021Target N V BiotechMajor ShareholderBuy75,000$20.53$1,539,750.006,100,564View SEC Filing Icon  
4/15/2021Thomas SpitznagelSVPSell5,000$30.91$154,550.005,000View SEC Filing Icon  
3/22/2021Ezio BonviniSVPSell3,917$32.00$125,344.0079,890View SEC Filing Icon  
3/22/2021James KarrelsCFOSell15,000$33.00$495,000.00View SEC Filing Icon  
3/8/2021Jeffrey Stuart PetersGeneral CounselSell21,749$26.50$576,348.5021,749View SEC Filing Icon  
See Full Table
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Full details and steps to take here.

SEC Filings (Institutional Ownership Changes) for MacroGenics (NASDAQ:MGNX)

96.89% of MacroGenics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MGNX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

MacroGenics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/26/2024Perceptive Advisors LLC611,932$5.89M0.1%N/A0.987%Search for SEC Filing on Google Icon
2/16/2024Price T Rowe Associates Inc. MD28,813$0.28M0.0%-12.7%0.046%Search for SEC Filing on Google Icon
2/16/2024GSA Capital Partners LLP123,716$1.19M0.1%-45.2%0.199%Search for SEC Filing on Google Icon
2/16/2024Public Employees Retirement System of Ohio9,144$88K0.0%-24.7%0.015%Search for SEC Filing on Google Icon
2/15/2024Exome Asset Management LLC125,900$1.21M1.2%N/A0.203%Search for SEC Filing on Google Icon
2/15/2024Virtus ETF Advisers LLC9,944$96K0.1%N/A0.016%Search for SEC Filing on Google Icon
2/15/2024Legal & General Group Plc9,457$91K0.0%+16.8%0.015%Search for SEC Filing on Google Icon
2/15/2024Barclays PLC157,531$1.52M0.0%+17.3%0.254%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.4,309,394$41.46M0.0%-2.4%6.947%Search for SEC Filing on Google Icon
2/15/2024Voya Investment Management LLC39,422$0.38M0.0%-24.1%0.064%Search for SEC Filing on Google Icon
2/15/2024Nuveen Asset Management LLC607,211$5.84M0.0%-35.1%0.979%Search for SEC Filing on Google Icon
2/15/2024Prelude Capital Management LLC30,200$0.29M0.0%+190.4%0.049%Search for SEC Filing on Google Icon
2/15/2024Price T Rowe Associates Inc. MD28,813$0.28M0.0%-12.7%0.046%Search for SEC Filing on Google Icon
2/15/2024Profund Advisors LLC16,424$0.16M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/15/2024Frazier Life Sciences Management L.P.2,401,704$23.10M1.2%+33.2%3.872%Search for SEC Filing on Google Icon
2/14/2024Royal Bank of Canada28,837$0.28M0.0%+44.5%0.046%Search for SEC Filing on Google Icon
2/14/2024Pathstone Holdings LLC13,050$0.13M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/14/2024Cubist Systematic Strategies LLC45,003$0.43M0.0%N/A0.073%Search for SEC Filing on Google Icon
2/14/2024Caxton Associates LP11,562$0.11M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/14/2024Pennant Investors LP43,800$0.42M0.1%N/A0.071%Search for SEC Filing on Google Icon
2/14/2024Putnam Investments LLC70,067$0.67M0.0%+66.5%0.113%Search for SEC Filing on Google Icon
2/14/2024Wasatch Advisors LP1,297,574$12.48M0.1%-7.9%2.092%Search for SEC Filing on Google Icon
2/14/2024Bellevue Group AG9,953,313$95.75M1.5%+1.5%16.046%Search for SEC Filing on Google Icon
2/14/2024Balyasny Asset Management L.P.38,947$0.38M0.0%+246.1%0.063%Search for SEC Filing on Google Icon
2/14/2024XML Financial LLC10,600$0.10M0.0%-27.4%0.017%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp774,479$7.45M0.0%+0.6%1.249%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 24,365$0.23M0.0%+185.8%0.039%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC4,572,000$43.98M0.6%-3.0%7.371%Search for SEC Filing on Google Icon
2/13/2024Goldman Sachs Group Inc.617,963$5.95M0.0%+23.1%0.996%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC94,732$0.91M0.0%N/A0.153%Search for SEC Filing on Google Icon
2/13/2024The Manufacturers Life Insurance Company 22,464$0.22M0.0%-12.8%0.036%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC93,005$0.90M0.1%N/A0.150%Search for SEC Filing on Google Icon
2/13/2024California State Teachers Retirement System10,017$96K0.0%-25.4%0.016%Search for SEC Filing on Google Icon
2/12/2024TD Asset Management Inc75,048$0.72M0.0%+15.7%0.121%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP58,679$0.56M0.0%-64.8%0.095%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG133,011$1.28M0.0%+32.4%0.214%Search for SEC Filing on Google Icon
2/9/2024Dynamic Technology Lab Private Ltd18,911$0.18M0.0%N/A0.030%Search for SEC Filing on Google Icon
2/8/2024Panagora Asset Management Inc.398,944$3.84M0.0%+5.4%0.643%Search for SEC Filing on Google Icon
2/8/2024Massachusetts Financial Services Co. MA165,107$1.59M0.0%-15.0%0.266%Search for SEC Filing on Google Icon
2/7/2024Principal Financial Group Inc.267,876$2.58M0.0%-2.8%0.432%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP1,214,900$11.69M0.0%-0.5%1.959%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC14,060$0.14M0.0%N/A0.023%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets42,109$0.41M0.0%+144.5%0.068%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.833,500$8.02M0.0%+1.0%1.344%Search for SEC Filing on Google Icon
2/6/2024AJOVista LLC5,344$51K0.1%N/A0.009%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank6,318$61K0.0%-8.9%0.010%Search for SEC Filing on Google Icon
2/6/2024Natixis Advisors L.P.30,892$0.30M0.0%N/A0.050%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.15,342$0.15M0.0%-47.1%0.025%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.803,375$7.73M0.0%-13.6%1.295%Search for SEC Filing on Google Icon
1/30/2024Cornercap Investment Counsel Inc.29,110$0.28M0.0%-17.6%0.047%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio67,300$0.65M0.0%-40.1%0.108%Search for SEC Filing on Google Icon
1/25/2024Allspring Global Investments Holdings LLC40,834$0.39M0.0%+64.4%0.066%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.49,337$0.48M0.0%+7.2%0.080%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.7,174$69K0.0%+349.2%0.012%Search for SEC Filing on Google Icon
1/19/2024Pinnacle Associates Ltd.687,980$6.62M0.1%-1.3%1.109%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC28,589$0.28M0.0%+36.9%0.046%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC30,085$0.29M0.0%+34.0%0.049%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.4,414,924$20.57M0.0%+0.8%7.118%Search for SEC Filing on Google Icon
12/1/2023Wellington Management Group LLP248,520$1.16M0.0%+3.0%0.401%Search for SEC Filing on Google Icon
11/24/2023Deutsche Bank AG25,155$0.12M0.0%-86.2%0.041%Search for SEC Filing on Google Icon
11/22/2023Graham Capital Management L.P.18,332$85K0.0%-14.4%0.030%Search for SEC Filing on Google Icon
11/17/2023Jacobs Levy Equity Management Inc.399,484$1.86M0.0%-1.4%0.644%Search for SEC Filing on Google Icon
11/15/2023RA Capital Management L.P.342,000$1.59M0.0%N/A0.551%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP225,918$1.05M0.1%+74.9%0.364%Search for SEC Filing on Google Icon
11/15/2023Rock Springs Capital Management LP1,178,796$5.49M0.1%+5.0%1.900%Search for SEC Filing on Google Icon
11/15/2023Sectoral Asset Management Inc.387,001$1.80M0.4%+9.8%0.624%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC4,712,000$21.96M0.3%-15.9%7.596%Search for SEC Filing on Google Icon
11/15/2023AQR Capital Management LLC340,610$1.59M0.0%+54.6%0.549%Search for SEC Filing on Google Icon
11/14/2023Corton Capital Inc.16,876$79K0.0%-77.1%0.027%Search for SEC Filing on Google Icon
11/14/2023Sherbrooke Park Advisers LLC21,219$99K0.0%N/A0.034%Search for SEC Filing on Google Icon
11/14/2023California State Teachers Retirement System13,429$63K0.0%-33.7%0.022%Search for SEC Filing on Google Icon
11/14/2023Tower Research Capital LLC TRC 8,524$40K0.0%+74.1%0.014%Search for SEC Filing on Google Icon
11/14/2023Trexquant Investment LP166,689$0.78M0.0%-4.8%0.269%Search for SEC Filing on Google Icon
11/13/2023Connor Clark & Lunn Investment Management Ltd.139,251$0.65M0.0%N/A0.224%Search for SEC Filing on Google Icon
11/13/2023Northern Trust Corp770,170$3.59M0.0%+2.6%1.242%Search for SEC Filing on Google Icon
11/13/2023Federated Hermes Inc.930,076$4.33M0.0%-1.2%1.499%Search for SEC Filing on Google Icon
11/13/2023Stifel Financial Corp43,186$0.20M0.0%-23.6%0.070%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC1,371,396$6.39M0.0%+7.8%2.211%Search for SEC Filing on Google Icon
11/13/2023Silverarc Capital Management LLC1,264,158$5.89M1.8%+4.0%2.038%Search for SEC Filing on Google Icon
11/13/2023Invesco Ltd.71,015$0.33M0.0%-86.0%0.114%Search for SEC Filing on Google Icon
11/13/2023WINTON GROUP Ltd31,647$0.15M0.0%N/A0.051%Search for SEC Filing on Google Icon
11/9/2023Deutsche Bank AG25,155$0.12M0.0%-86.2%0.041%Search for SEC Filing on Google Icon
11/9/2023UBS Group AG100,471$0.47M0.0%-4.7%0.162%Search for SEC Filing on Google Icon
11/8/2023Charles Schwab Investment Management Inc.825,389$3.85M0.0%+14.4%1.332%Search for SEC Filing on Google Icon
11/8/2023Massachusetts Financial Services Co. MA194,204$0.91M0.0%+32.9%0.313%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC134,273$0.62M0.0%+15.2%0.217%Search for SEC Filing on Google Icon
11/6/2023Los Angeles Capital Management LLC60,329$0.28M0.0%N/A0.097%Search for SEC Filing on Google Icon
11/2/2023Principal Financial Group Inc.275,550$1.28M0.0%+0.9%0.445%Search for SEC Filing on Google Icon
10/31/2023Panagora Asset Management Inc.378,660$1.77M0.0%-1.3%0.611%Search for SEC Filing on Google Icon
10/27/2023Allspring Global Investments Holdings LLC24,840$0.12M0.0%-60.4%0.040%Search for SEC Filing on Google Icon
10/26/2023Strs Ohio112,400$0.52M0.0%+59.7%0.181%Search for SEC Filing on Google Icon
10/24/2023Pinnacle Associates Ltd.697,067$3.25M0.1%-1.8%1.125%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC20,877$97K0.0%N/A0.034%Search for SEC Filing on Google Icon
10/11/2023Vontobel Holding Ltd.387,001$1.80M0.0%+9.8%0.625%Search for SEC Filing on Google Icon
8/21/2023California State Teachers Retirement System20,245$0.11M0.0%-9.7%0.033%Search for SEC Filing on Google Icon
8/15/2023Wells Fargo & Company MN23,986$0.13M0.0%+121.0%0.039%Search for SEC Filing on Google Icon
8/15/2023Woodline Partners LP364,700$1.95M0.0%N/A0.589%Search for SEC Filing on Google Icon
8/15/2023XTX Topco Ltd51,343$0.28M0.0%-8.7%0.083%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.398,646$2.13M0.0%+20.3%0.643%Search for SEC Filing on Google Icon
8/15/2023Captrust Financial Advisors16,116$86K0.0%N/A0.026%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
MacroGenics logo
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 × CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. In addition, it develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3;Retifanlimab, an monoclonal antibody used for cancer therapeutics; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company develops MGD014 and MGD020, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and CD3 on T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.
Read More on MacroGenics

Today's Range

Now: $19.06
Low: $18.06
High: $19.39

50 Day Range

MA: $13.81
Low: $9.62
High: $19.06

52 Week Range

Now: $19.06
Low: $4.29
High: $19.39

Volume

2,004,569 shs

Average Volume

1,346,368 shs

Market Capitalization

$1.18 billion

P/E Ratio

23.83

Dividend Yield

N/A

Beta

2.12

Who are the company insiders with the largest holdings of MacroGenics?

MacroGenics' top insider shareholders include:
  1. Target N V Biotech (Major Shareholder)
  2. James Karrels (CFO)
  3. Ezio Bonvini (SVP)
  4. Edward Hurwitz (Director)
  5. Jeffrey Stuart Peters (VP)
Learn More about top insider investors at MacroGenics.

Who are the major institutional investors of MacroGenics?

MacroGenics' top institutional investors include:
  1. Bellevue Group AG — 16.05%
  2. Armistice Capital LLC — 7.37%
  3. Vanguard Group Inc. — 6.95%
  4. Frazier Life Sciences Management L.P. — 3.87%
  5. Wasatch Advisors LP — 2.09%
  6. Dimensional Fund Advisors LP — 1.96%
Learn More about top institutional investors of MacroGenics stock.

Which major investors are selling MacroGenics stock?

During the last quarter, MGNX stock was sold by these institutional investors:
  1. Nuveen Asset Management LLC
  2. Armistice Capital LLC
  3. Federated Hermes Inc.
  4. Wasatch Advisors LP
  5. Trexquant Investment LP
  6. Vanguard Group Inc.
  7. GSA Capital Partners LLP
  8. Strs Ohio
In the previous year, company insiders that have sold MacroGenics company stock include:
  1. Target N V Biotech (Major Shareholder)
  2. James Karrels (CFO)
Learn More investors selling MacroGenics stock.

Which major investors are buying MacroGenics stock?

During the previous quarter, MGNX stock was purchased by institutional investors including:
  1. Perceptive Advisors LLC
  2. Frazier Life Sciences Management L.P.
  3. Bellevue Group AG
  4. Exome Asset Management LLC
  5. Goldman Sachs Group Inc.
  6. Rafferty Asset Management LLC
  7. Campbell & CO Investment Adviser LLC
  8. Cubist Systematic Strategies LLC
Within the previous year, these company insiders have bought MacroGenics stock:
  1. Target N V Biotech (Major Shareholder)
  2. James Karrels (CFO)
  3. Ezio Bonvini (SVP)
Learn More investors buying MacroGenics stock.
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Full details and steps to take here.